https://pubmed.ncbi.nlm.nih.gov/31675127/
Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes Depends on the Study Population.
CHDR
Prins S, Zhuparris A, Groeneveld GJ
https://pubmed.ncbi.nlm.nih.gov/31675127/